ArticlePloS one2026
The global burden of age-related hearing loss among individuals aged 60 years and older: An analysis for the global burden of disease study 2021 and predictions to 2050.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Serum metabolomic profiling identifies a biomarker panel associated with age-related hearing loss.Biochemistry and biophysics reports · 2026Article
- Prevalence of Hearing Loss and Years Lived With Disability in Ethiopia From 1990 to 2023: A Subnational Analysis for the Global Burden of Diseases Study.SAGE open nursingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAge-related hearing loss (ARHL) impacts communication, cognitive function, and mental health, with regional prevalence variation. We analyzed global spatial and temporal trends in ARHL burden from 1990 to 2021.
methodsData on ARHL prevalence and years lived with disability (YLDs) among individuals aged 60 and older were analyzed. Estimated annual percentage changes (EAPC) in the age-standardized prevalence (ASPR) and YLD rates (ASYR) were analyzed by country, gender and socio-demographic index (SDI). Age-period-cohort, decomposition analyses, and frontier analysis identified influencing factors and quantify inequalities. Future trends were predicted using Bayesian model.
resultsFrom 1990 to 2021, global ARHL prevalence cases increased by 137.43% (302.79 million to 718.93 million), with a 4.34% rise in ASPR. YLDs grew by 144.3% (10.76 million to 26.30 million), and ASYR rose by 4.45%. Males exhibited higher ASPR and ASYR despite more cases among females. High-middle and middle SDI regions showing higher and steadily increasing ASPR and ASYR, while high SDI regions exhibited the lowest and most stable rates. Population growth was the primary driver of the increasing burden. Projections indicate continued growth in ARHL cases by 2050.
conclusionsThe ARHL burden among older adults has increased significantly, with marked regional and socio-demographic disparities. Lower SDI regions bear disproportionately higher burdens. Effective strategies, including public education, hearing protection, early screening, and research into treatments, are urgently needed to address this public health challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.